You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 3050Biotin 721FITC 702HRP 688PE 621APC 453Cy3 418AP 417PerCP 371BF488 358PE/Cy5 358APC/Cy5.5 357APC/Cy7 357BF405 357BF647 357PE/Cy5.5 357PE/Cy7 357PerCP/Cy5.5 357BF555 356Pacific Blue 356PerCP/Cy7 356BF350 355BF594 355BF680 355BF700 355BF750 355Cy5 355Cy5.5 355RBITC 355Cy7 354IRDye800 261AE 75iFluor647 62RPE 14SureLight 488 6IRDye800CW 2MMAE 1
Biologically Active
Featured Product
Human TRAIL [orb2995246]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.5 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human NOL3 [orb2995203]
Unconjugated
SDS-PAGE: Greater than 85% as determined by reducing SDS-PAGE.
Predicted: 48.92 KDa. Observed: 30-59 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human AIF [orb2995176]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.2 KDa. Observed: 68 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human TRAIL R2 [orb2995140]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.3 KDa. Observed: 16-22 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human TRAIL R3 [orb2995031]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 21.78 KDa. Observed: 38-58 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Human PDCD10 [orb2994641]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.9 KDa. Observed: 28 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human BIRC5 [orb2994652]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 16-18 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human PDCD5 [orb2994625]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 20 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse CD5L [orb2994911]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.43 KDa. Observed: 52 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Biotinylated Human PCSK9 [orb2993452]
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14&62 KDa. Observed: 18&58-70&90-150 KDa, reducing conditions
20 μg, 100 μg